相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis
Markus Brueckner et al.
JOURNAL OF CROHNS & COLITIS (2012)
Green tea EGCG, T cells, and T cell-mediated autoimmune diseases
Dayong Wu et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Warren Strober et al.
GASTROENTEROLOGY (2011)
Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis
Vivianne Bergeron et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
Francis A. Farraye et al.
GASTROENTEROLOGY (2010)
Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expression
Barry J. M. Ripley et al.
INTERNATIONAL IMMUNOLOGY (2010)
Laboratory, Epidemiological, and Human Intervention Studies Show That Tea (Camellia sinensis) May Be Useful in the Prevention of Obesity
Kimberly A. Grove et al.
JOURNAL OF NUTRITION (2010)
Green tea polyphenol epigallocatechi3-gallate: Inflammation and arthritis
Rashmi Singh et al.
LIFE SCIENCES (2010)
Epigallocatechin gallate mediated protection against tumor necrosis factor-α-induced monocyte chemoattractant protein-1 expression is heme oxygenase-1 dependent
Yuanyuan Zheng et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Multitargeted therapy of cancer by green tea polyphenols
Naghma Khan et al.
CANCER LETTERS (2008)
Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis
Patricia A. Abboud et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
SOCS proteins, cytokine signalling and immune regulation
Akihiko Yoshimura et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate
N Khan et al.
CANCER RESEARCH (2006)
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation
A Mansell et al.
NATURE IMMUNOLOGY (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
(-)-epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells
M Shimizu et al.
CLINICAL CANCER RESEARCH (2005)
Cancer chemoprevention with dietary phytochemicals
YJ Surh
NATURE REVIEWS CANCER (2003)
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma
A Jatoi et al.
CANCER (2003)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
分享论文
